October 30, 2025

Dompé's Program in NAION Selected for FDA Commissioner’s National Priority Voucher Program

Dompé says it plans to apply the voucher to its Biologics License Application for an intranasal form of nerve growth factor (Cenegermin-bkbj) for the treatment of non-arteritic anterior ischemic optic neuropathy (NAION).

Optometric Management

October 30, 2025

Prevent Blindness Offers Patient Education Tools, Resources for Diabetes-Related Eye Disease Month

Prevent Blindness has announced a suite of new educational tools and resources in recognition of Diabetes-related Eye Disease Month this November, aimed at helping patients understand and manage the vision complications associated with diabetes.

Ophthalmology Management

April 24, 2025

FDA Rejects Extended Dosing Intervals for Eylea HD

The agency did not agree with Regeneron’s proposal to add dosing intervals greater than every 16 weeks, the maximum interval currently indicated for aflibercept 8 mg injections.

Retinal Physician

February 26, 2025

Integration of Vision Services Remains an Unmet Need in FQHCs

Telemedicine, funding, and provider partnerships can help, researchers say.

Conexiant

April 09, 2025

Port Delivery System With Ranibizumab for Diabetic Eye Disease

Researchers determined that the PDS may decrease the treatment burden of frequent intravitreal injections, but further research on efficacy and safety is needed.

Conexiant

April 02, 2025

GLP-1 RAs Evaluated for Long-Term Risk of NAION in Patients With Diabetes

Researchers’ subgroup analyses provide data on increased risks according to timepoint, demographics, and comorbidities.

Conexiant

August 05, 2025

Large US Study Adds to Connection Between NAION Risks and GLP-1 Drugs

Semaglutide and liraglutide showed the highest risk, while dulaglutide and exenatide were not significantly associated with NAION.

Ophthalmology Management

November 08, 2024

Is Intravenous Methylprednisolone Efficacious for Visual Complications of GCA?

While timely treatment is essential to protect vision, the researchers found no visual acuity benefit with IVMP.

Conexiant

December 03, 2024

Novel Eye Perfusion Model Advances Retinal Disease Research

Innovative perfusion techniques recreate physiological conditions in the retina, offering a powerful tool for studying blindness and eye diseases.

Conexiant